Template:Metoprolol: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) mNo edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 23: | Line 23: | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Metoprolol clinical pharmacology|Clinical Pharmacology]] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Metoprolol clinical pharmacology|Clinical Pharmacology]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Metoprolol clinical studies|Clinical Studies]] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Metoprolol clinical studies|Clinical Studies]] | ||
| Line 33: | Line 31: | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Metoprolol labels and packages|Labels and Packages]] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Metoprolol labels and packages|Labels and Packages]] | ||
|- | |||
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | TOPROL XL<sup>®</sup> FDA Package Insert | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Metoprolol succinate indications and usage|Indications and Usage]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Metoprolol succinate dosage and administration|Dosage and Administration]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Metoprolol succinate contraindications|Contraindications]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Metoprolol succinate warnings and precautions|Warnings and Precautions]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Metoprolol succinate adverse reactions|Adverse Reactions]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Metoprolol succinate drug interactions|Drug Interactions]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Metoprolol succinate use in specific populations|Use in Specific Populations]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Metoprolol succinate overdosage|Overdosage]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Metoprolol succinate description|Description]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Metoprolol succinate clinical pharmacology|Clinical Pharmacology]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Metoprolol succinate clinical studies|Clinical Studies]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Metoprolol succinate how supplied storage and handling|How Supplied/Storage and Handling]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Metoprolol succinate patient counseling information|Patient Counseling Information]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Metoprolol succinate labels and packages|Labels and Packages]] | |||
|- | |- | ||
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Clinical Trials on Metoprolol | ! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Clinical Trials on Metoprolol | ||